Perspective Therapeutics Inc.
Perspective Therapeutics, Inc., together with its subsidiaries, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. The company discovers, and develop its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors tha… Read more
Perspective Therapeutics Inc. (CATX) - Total Assets
Latest total assets as of September 2025: $294.82 Million USD
Based on the latest financial reports, Perspective Therapeutics Inc. (CATX) holds total assets worth $294.82 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Perspective Therapeutics Inc. - Total Assets Trend (1994–2024)
This chart illustrates how Perspective Therapeutics Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Perspective Therapeutics Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Perspective Therapeutics Inc.'s total assets of $294.82 Million consist of 67.8% current assets and 32.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 18.1% |
| Accounts Receivable | $116.00K | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $50.00 Million | 14.7% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (1994–2024)
This chart illustrates how Perspective Therapeutics Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Perspective Therapeutics Inc.'s current assets represent 67.8% of total assets in 2024, an increase from 29.3% in 1994.
- Cash Position: Cash and equivalents constituted 18.1% of total assets in 2024, up from 14.9% in 1994.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 14.0% of total assets, an increase from 0.0% in 1994.
- Asset Diversification: The largest asset category is intangible assets at 14.7% of total assets.
Perspective Therapeutics Inc. Competitors by Total Assets
Key competitors of Perspective Therapeutics Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Perspective Therapeutics Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Perspective Therapeutics Inc. generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Perspective Therapeutics Inc. is currently not profitable relative to its asset base.
Perspective Therapeutics Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 8.66 | 9.60 | 3.50 |
| Quick Ratio | 8.66 | 9.60 | 3.09 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $157.88 Million | $ 242.03 Million | $ 3.93 Million |
Perspective Therapeutics Inc. - Advanced Valuation Insights
This section examines the relationship between Perspective Therapeutics Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.46 |
| Latest Market Cap to Assets Ratio | 0.76 |
| Asset Growth Rate (YoY) | 248.4% |
| Total Assets | $341.10 Million |
| Market Capitalization | $259.26 Million USD |
Valuation Analysis
Below Book Valuation: The market values Perspective Therapeutics Inc.'s assets below their book value (0.76 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Perspective Therapeutics Inc.'s assets grew by 248.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Perspective Therapeutics Inc. (1994–2024)
The table below shows the annual total assets of Perspective Therapeutics Inc. from 1994 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $341.10 Million | +248.45% |
| 2023-12-31 | $97.89 Million | +68.51% |
| 2023-06-30 | $58.09 Million | 0.00% |
| 2022-12-31 | $58.09 Million | -9.85% |
| 2022-06-30 | $64.44 Million | 0.00% |
| 2021-12-31 | $64.44 Million | -8.49% |
| 2021-06-30 | $70.42 Million | +353.92% |
| 2020-12-31 | $15.51 Million | +78.33% |
| 2020-06-30 | $8.70 Million | 0.00% |
| 2019-12-31 | $8.70 Million | -7.67% |
| 2019-06-30 | $9.42 Million | 0.00% |
| 2018-12-31 | $9.42 Million | +26.38% |
| 2018-06-30 | $7.46 Million | -39.24% |
| 2017-12-31 | $12.27 Million | 0.00% |
| 2017-06-30 | $12.27 Million | -32.22% |
| 2016-12-31 | $18.10 Million | 0.00% |
| 2016-06-30 | $18.10 Million | -21.31% |
| 2015-12-31 | $23.00 Million | 0.00% |
| 2015-06-30 | $23.00 Million | -13.36% |
| 2014-12-31 | $26.55 Million | 0.00% |
| 2014-06-30 | $26.55 Million | +276.30% |
| 2013-12-31 | $7.06 Million | 0.00% |
| 2013-06-30 | $7.06 Million | -6.00% |
| 2012-12-31 | $7.51 Million | 0.00% |
| 2012-06-30 | $7.51 Million | -4.86% |
| 2011-12-31 | $7.89 Million | 0.00% |
| 2011-06-30 | $7.89 Million | -0.68% |
| 2010-12-31 | $7.94 Million | 0.00% |
| 2010-06-30 | $7.94 Million | -32.35% |
| 2009-12-31 | $11.74 Million | 0.00% |
| 2009-06-30 | $11.74 Million | -34.08% |
| 2008-12-31 | $17.81 Million | 0.00% |
| 2008-06-30 | $17.81 Million | -31.69% |
| 2007-12-31 | $26.08 Million | 0.00% |
| 2007-06-30 | $26.08 Million | +361.04% |
| 2006-12-31 | $5.66 Million | 0.00% |
| 2006-06-30 | $5.66 Million | -82.64% |
| 2005-06-30 | $32.59 Million | 0.00% |
| 2004-12-31 | $32.59 Million | +3519014.47% |
| 2004-06-30 | $926.00 | 0.00% |
| 2003-12-31 | $926.00 | 0.00% |
| 2003-06-30 | $926.00 | 0.00% |
| 2002-12-31 | $926.00 | 0.00% |
| 2002-06-30 | $926.00 | -3.44% |
| 2001-12-31 | $959.00 | +0.42% |
| 2000-12-31 | $955.00 | -0.42% |
| 2000-06-30 | $959.00 | -99.92% |
| 1999-12-31 | $1.17 Million | +122847.23% |
| 1999-06-30 | $955.00 | -99.93% |
| 1998-12-31 | $1.31 Million | +11.74% |
| 1998-06-30 | $1.17 Million | -32.56% |
| 1997-12-31 | $1.74 Million | +32.70% |
| 1997-06-30 | $1.31 Million | -33.19% |
| 1996-12-31 | $1.96 Million | +12.80% |
| 1996-06-30 | $1.74 Million | -39.48% |
| 1995-12-31 | $2.88 Million | +46.49% |
| 1995-06-30 | $1.96 Million | -31.74% |
| 1994-12-31 | $2.88 Million | 0.00% |
| 1994-06-30 | $2.88 Million | -- |